Omnicell Inc (FRA:OC9)
€ 44.4 -0.6 (-1.33%) Market Cap: 2.07 Bil Enterprise Value: 2.10 Bil PE Ratio: 0 PB Ratio: 1.76 GF Score: 70/100

Omnicell Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 06:15PM GMT
Release Date Price: €79 (+2.60%)
Jailendra P. Singh;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. I guess we will get started. Hello, everyone. I'm Jailendra Singh, health care technology and distribution analyst at Credit Suisse. Thanks, everyone, for joining us. Next up, we have Omnicell. From the company, we have Peter Kuipers, Executive VP and CFO; and Kathleen Nemeth, VP of IR. Omnicell is a leading provider of solutions targeting patient safety and operational efficiency in health care facilities. Peter joined Omnicell in 2015 as Executive VP and CFO. Peter and Kathleen will begin with a quick 20, 25 minutes presentation, and we will then open the line for Q&A. With that, Peter, over to you.

Peter J. Kuipers;Jailendra P. Singh;dit Suisse AG
Omnicell, Inc. - Executive VP & CFO;CrÃ

Thank you, Jailendra. It's great to be here and talk to everyone, give an update on the business and the strategy. We do have a presentation, I think, that we can show. Let's go ahead and do that.

- ©

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot